Bringing Clinical Trials To Patients With The Decentralized Model
By Rosamund Round, Vice President, Patient Innovation Center, Parexel®
Before the pandemic, Parexel was experienced at executing decentralized clinical trials to improve patient access and experiences. Since, COVID-19, which has had a huge impact on global clinical trials, sponsors, CROs, sites, and patients have pivoted to adapt to a more home- or community-based approach. More than 100 DCTs later, Parexel is at the forefront of industry change.
“Everything we do is built around the patient and caregiver to make participation as easy as possible.” says Rosamund Round, Vice President of Parexel’s Patient Innovation Center. Central to navigating the dynamic research landscape is Parexel’s ability to harness and apply patient insights during DCT planning to ensure that every part of the strategy is formulated with the patient in mind. This approach, along with expertise in global regulatory requirements, tech